This information was published on 2021-05-03T08:06:54 for IP Right Registration Published.
| Field | Value |
| (210) | 2126383 |
| (220) |
07 Oct 2020
|
| (300) |
US, 22 Sep 2020, 90199697
|
| (511) (510) |
Class 1
Diagnostic reagents for scientific or research use in the field of breast, ovarian, bladder, lung, pancreatic, and prostate cancer; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of breast, ovarian, bladder, lung, pancreatic, or prostate cancer Class 5 Diagnostic reagents for medical use in the field of breast, ovarian, bladder, lung, pancreatic, or prostate cancer; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of breast, ovarian, bladder, lung, pancreatic, or prostate cancer |
| (540) |
|
| (730) |
Veracyte, Inc
|
| (750) |
Thomson Geer
|
Find out more about publications on the About page.